Comparing the Relative Importance of Attributes of Metastatic Renal Cell Carcinoma Treatments to Patients and Physicians in the United States: A Discrete-Choice Experiment

Comparing the Relative Importance of Attributes of Metastatic Renal Cell Carcinoma Treatments to... PharmacoEconomics https://doi.org/10.1007/s40273-018-0640-7 ORIGINAL RESEARCH ARTICLE Comparing the Relative Importance of Attributes of Metastatic Renal Cell Carcinoma Treatments to Patients and Physicians in the United States: A Discrete-Choice Experiment 1 2 3 3 • • • • Juan Marcos Gonza ´ lez Justin Doan David J. Gebben Marco Boeri Mayer Fishman Springer International Publishing AG, part of Springer Nature 2018 Abstract attributes conditional on the range of levels of that Objectives Value assessments of new treatments for attribute). metastatic renal cell carcinoma (RCC) should include Results Overall, 201 patients and 142 physicians com- outcomes that are most important to patients. This study pleted the survey. For both patients and physicians, PL3Y aimed to quantify and compare the conditional relative was the attribute with the greatest and statistically signifi- importance of the attributes of RCC treatments to patients cant conditional relative importance. Estimates of the and physicians in the United States. conditional relative importance of PFS, skin reactions, and Methods Patients with RCC and physicians who treat RCC mode of administration for patients, and for PFS and mode completed an online discrete-choice experiment survey of administration for physicians, were not statistically with a fractional factorial D-optimal experimental design. significant. The preferences http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png PharmacoEconomics Springer Journals

Comparing the Relative Importance of Attributes of Metastatic Renal Cell Carcinoma Treatments to Patients and Physicians in the United States: A Discrete-Choice Experiment

Loading next page...
 
/lp/springer_journal/comparing-the-relative-importance-of-attributes-of-metastatic-renal-1IsxZfxW0u
Publisher
Springer International Publishing
Copyright
Copyright © 2018 by Springer International Publishing AG, part of Springer Nature
Subject
Medicine & Public Health; Pharmacoeconomics and Health Outcomes; Quality of Life Research; Health Economics; Health Administration; Public Health
ISSN
1170-7690
eISSN
1179-2027
D.O.I.
10.1007/s40273-018-0640-7
Publisher site
See Article on Publisher Site

Abstract

PharmacoEconomics https://doi.org/10.1007/s40273-018-0640-7 ORIGINAL RESEARCH ARTICLE Comparing the Relative Importance of Attributes of Metastatic Renal Cell Carcinoma Treatments to Patients and Physicians in the United States: A Discrete-Choice Experiment 1 2 3 3 • • • • Juan Marcos Gonza ´ lez Justin Doan David J. Gebben Marco Boeri Mayer Fishman Springer International Publishing AG, part of Springer Nature 2018 Abstract attributes conditional on the range of levels of that Objectives Value assessments of new treatments for attribute). metastatic renal cell carcinoma (RCC) should include Results Overall, 201 patients and 142 physicians com- outcomes that are most important to patients. This study pleted the survey. For both patients and physicians, PL3Y aimed to quantify and compare the conditional relative was the attribute with the greatest and statistically signifi- importance of the attributes of RCC treatments to patients cant conditional relative importance. Estimates of the and physicians in the United States. conditional relative importance of PFS, skin reactions, and Methods Patients with RCC and physicians who treat RCC mode of administration for patients, and for PFS and mode completed an online discrete-choice experiment survey of administration for physicians, were not statistically with a fractional factorial D-optimal experimental design. significant. The preferences

Journal

PharmacoEconomicsSpringer Journals

Published: Jun 5, 2018

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off